In the ever-evolving field of genetic testing, one of the most significant advancements has been the development of liquid biopsy (Liquid Bx.) techniques. These innovative methods allow for the non-invasive detection of genetic mutations from circulating tumor DNA (ctDNA) in blood samples. Among these, the Cell-Free EGFR T790M/L858R Exon 19 Deletion Test stands out for […]











